Preterm birth in Sjogren-Larsson syndrome

Neuropediatrics

Volumn 30, Issue 6, 1999, Pages 325-327

  Willemsen, M A A P ^a   Rotteveel, J J ^a   Van Domburg, P H M F ^b   Gabreels F J M ^a   Mayatepek, E ^c   Sengers, R C A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LAURENTIUS HOSPITAL   (Netherlands)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Fatty aldehyde dehydrogenase; Leukotriene B4; Preterm birth; Sjogren Larsson syndrome; Spasticity

Indexed keywords

ALDEHYDE DEHYDROGENASE; LEUKOTRIENE B4;

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; CHILD; CLINICAL ARTICLE; FEMALE; GESTATIONAL AGE; HUMAN; MALE; NEWBORN; NEWBORN HEMOLYTIC DISEASE; NEWBORN PERIOD; PREMATURITY; PRIORITY JOURNAL; SJOEGREN LARSSON SYNDROME; SPASTICITY; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE;

ALDEHYDE DEHYDROGENASE; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PREGNANCY; SJOGREN-LARSSON SYNDROME;

EID: 0033233318     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-973513     Document Type: Article

References (17)

1. De Laurenzi V, Rogers CR, Hamrock DJ, Marekov LN, Steinert PM, Compton JG, et al. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nat Genet 1996; 12: 52-57
2. Dudley DJ. Immunoendocrinology of preterm labor: the link between corticotropin-releasing hormone and inflammation. Am J Obstet Gynecol 1999; 180: S251-256
3. Jagell S, Polland W, Sandgren O. Specific changes in the fundus typical for the Sjögren-Larsson syndrome. An ophthalmological study of 35 patients. Acta Ophthalmol 1980; 58: 321-330
4. Jagell S, Heijbel J. Sjögren-Larsson syndrome: physical and neurological features. A survey of 35 patients. Helv Paediat Acta 1982; 37: 519-530
5. James PF, Zoeller RA. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. J Biol Chem 1997; 272: 23532-23539
6. Joseph KS, Kramer MS, Marcoux S, Ohlsson A, Wu Wen S, Allen A, et al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med 1998; 339: 1434-1439
7. Keelan JA, Coleman M, Mitchell MD. The molecular mechanisms of term and preterm labor: recent progress and clinical implications. Clin Obstet Gynecol 1997; 40: 460-478
8. Lacour M. Update on Sjögren-Larsson syndrome. Dermatology 1996; 193: 77-82
9. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J Med 1990; 323: 645-655
10. 4 release in early pregnancy and in term and preterm labour. Early Hum Dev 1990; 23: 93-99
11. Maaswinkel-Mooij PD, Brouwer OF, Rizzo WB. Unsuccessful dietary treatment of Sjögren-Larsson syndrome. J Pediatr 1994; 124: 748-750
12. Mayatepek E, Hoffmann GF. Leukotrienes: biosynthesis, metabolism, and pathophysiologic significance. Pediatr Res 1995; 37: 1-9
13. Rizzo WB. Sjögren-Larsson syndrome. Semin Dermatol 1993; 12: 210-218
14. Sjögren T, Larsson T. Oligophrenia in combination with congenital ichthyosis and spastic disorders. Acta Psychiatr Neurol Scand 1957; 32: 1-113
15. Van Domburg PHMF, Willemsen MAAP, Rotteveel JJ, DeJong JGN, Thijssen HOM, Heerschap A, et al. Sjögren-Larsson syndrome. Clinical and MRI/MRS findings in FALDH-deficient patients. Neurology 1999; 52: 1345-1352
16. 4 in patients with Sjögren-Larsson syndrome. J Pediatr, in press.
17. 4 release by human fetal membranes at term gestation. Prostaglandins 1997; 54: 539-547